Peroxynitrite inactivates tissue plasminogen activatorNIELSEN, Vance G; CROW, John P; FEN ZHOU et al.Anesthesia and analgesia. 2004, Vol 98, Num 5, pp 1312-1317, issn 0003-2999, 6 p.Article

Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrinMUTCH, Nicola J; ENGEL, Ruchira; DE WILLIGE, Shirley Uitte et al.Blood. 2010, Vol 115, Num 19, pp 3980-3988, issn 0006-4971, 9 p.Article

Isolated limb perfusion with tissue plasminogen activator for acute hand ischemiaGILANI, Ramyar; GREENBERG, Roy K; JOHNSTON, Douglas R et al.Journal of vascular surgery. 2009, Vol 50, Num 3, pp 659-662, issn 0741-5214, 4 p.Article

Résultats ASSENT II (1), et suivi à un an, ASSENT III (2) = TNT - ASSENT-2 results and one-year follow-up, ASSENT-3BASSAND, J. P.Médecine d'urgence (Paris). 2001, Vol 23, Num SEP, pp 224-228, issn 1148-8115, HSConference Paper

The macrophage and fibrinolysisLOSCALZO, J.Seminars in thrombosis and hemostasis. 1996, Vol 22, Num 6, pp 503-506, issn 0094-6176Article

Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regenerationOHKI, Makiko; OHKI, Yuichi; ZHENPING ZHU et al.Blood. 2010, Vol 115, Num 21, pp 4302-4312, issn 0006-4971, 11 p.Article

Antifibrinolytic agents reduce tissue plasminogen activator-mediated neuronal toxicity in vitroSUN, H.-Y; SZLAM, F; LEVY, J. H et al.Acta anaesthesiologica scandinavica. 2009, Vol 53, Num 3, pp 325-331, issn 0001-5172, 7 p.Article

Binding of tissue-plasminogen activator to fibrin : Effect of ultrasoundSIDDIQI, F; ODRLJIN, T. M; FAY, P. J et al.Blood. 1998, Vol 91, Num 6, pp 2019-2025, issn 0006-4971Article

Intravenous administration of recombinant tissue plasminogen activator : optimizing the rate of coronary thrombolysisPREWITT, R. M; SHIAN GU; SCHICK, U et al.Chest. 1995, Vol 107, Num 4, pp 1146-1151, issn 0012-3692Article

Tissue plasminogen activator : Beyond thrombolysisBENARROCH, Eduardo E.Neurology. 2007, Vol 69, Num 8, pp 799-802, issn 0028-3878, 4 p.Article

Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?QURESHI, A. I; EZZEDDINE, M. A; NASAR, A et al.Neurology. 2006, Vol 66, Num 8, pp 1171-1174, issn 0028-3878, 4 p.Article

Intravitreous Tissue Plasminogen Activator With Pneumatic Displacement in Submacular HemorrhageRATRA, Dhanashree; BASIA, Amit.Archives of ophthalmology (1960). 2012, Vol 130, Num 6, pp 795-796, issn 0003-9950, 2 p.Article

Intravitreal Tissue Plasminogen Activator and Pneumatic Displacement of Submacular HemorrhageKUNG, Ya-Hsin; WU, Tsung-Tien; HONG, May-Ching et al.Journal of ocular pharmacology and therapeutics. 2010, Vol 26, Num 5, pp 469-474, issn 1080-7683, 6 p.Article

Inhibition of endothelial cell thromboresistance by homocysteineQI LING; HAJJAR, K. A.The Journal of nutrition. 2000, Vol 130, Num 2, pp 373S-376S, issn 0022-3166, SUPConference Paper

The fibrinolytic system in neoplasiaBELL, W. R.Seminars in thrombosis and hemostasis. 1996, Vol 22, Num 6, pp 459-478, issn 0094-6176Article

Freeze-dried fibrinogen or fibrinogen in EDTA stimulate the tissue-type plasminogen activator-catalysed conversion of plasminogen to plasminHADDELAND, U; SLETTEN, K; BENNICK, A et al.Blood coagulation & fibrinolysis. 1994, Vol 5, Num 4, pp 575-581, issn 0957-5235Article

Β₂-Glycoprotein I Is a Cofactor for Tissue Plasminogen Activator-Mediated Plasminogen ActivationCHUNYA BU; LEI GAO; WEIDONG XIE et al.Arthritis and rheumatism. 2009, Vol 60, Num 2, pp 559-568, issn 0004-3591, 10 p.Article

Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activatorCHEN, W; HUANG, X; MA, X-W et al.Eye (London. 1987). 2008, Vol 22, Num 2, pp 300-307, issn 0950-222X, 8 p.Article

Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unitPOLAVARAPU, Rohini; CAROLINA GONGORA, Maria; HONG YI et al.Blood. 2007, Vol 109, Num 8, pp 3270-3278, issn 0006-4971, 9 p.Article

The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastographyKATORI, Nobuyuki; TANAKA, Kenichi A; SZLAM, Fania et al.Anesthesia and analgesia. 2005, Vol 100, Num 6, pp 1781-1785, issn 0003-2999, 5 p.Article

Streptokinase-a clinically useful thrombolytic agentBANEJEE, Anirban; CHISTI, Yusuf; BANEJEE, U. C et al.Biotechnology advances. 2004, Vol 22, Num 4, pp 287-307, issn 0734-9750, 21 p.Article

Gewebe-Plasminogen Aktivator : Ein vielfältig einsetzbares Enzym in der Augenheilkunde = Tissue-plasminagen activator. An enzyme with many uses in ophthalmologyHESSE, L.Der Ophthalmologe (Berlin. Print). 1997, Vol 94, Num 5, pp 366-371, issn 0941-293XArticle

Identification of carbohydrate structures in glycoprotein peptide maps by the use of LC/MS with selected ion extraction with special reference to tissue plasminogen activator and a glycosylation variant produced by site directed mutagenesisGUZZETTA, A. W; BASA, L. J; HANCOCK, W. S et al.Analytical chemistry (Washington, DC). 1993, Vol 65, Num 21, pp 2953-2962, issn 0003-2700Article

Human tissue-type plasminogen activatorKRUITHOF, Egbert K. O; DUNOYER-GEINDRE, Sylvie.Thrombosis and haemostasis. 2014, Vol 112, Num 2, pp 243-254, issn 0340-6245, 12 p.Article

Factor XIII and Tranexamic Acid But Not Recombinant Factor VIIa Attenuate Tissue Plasminogen Activator-Induced Hyperfibrinolysis in Human Whole BloodDIRKMANN, Daniel; GÖRLINGER, Klaus; GISBERTZ, Caroline et al.Anesthesia and analgesia. 2012, Vol 114, Num 6, pp 1182-1188, issn 0003-2999, 7 p.Article